Lincoln National Corp Purchases Shares of 1,778 iShares Nasdaq Biotechnology ETF (IBB)

Lincoln National Corp bought a new position in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 1,778 shares of the financial services provider’s stock, valued at approximately $217,000.

Other hedge funds also recently made changes to their positions in the company. Benjamin F. Edwards & Company Inc. lifted its position in shares of iShares Nasdaq Biotechnology ETF by 636.4% during the third quarter. Benjamin F. Edwards & Company Inc. now owns 891 shares of the financial services provider’s stock worth $109,000 after purchasing an additional 770 shares in the last quarter. Schroder Investment Management Group acquired a new position in shares of iShares Nasdaq Biotechnology ETF during the second quarter worth approximately $105,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in shares of iShares Nasdaq Biotechnology ETF during the second quarter worth approximately $134,000. KHP Capital LLC lifted its position in shares of iShares Nasdaq Biotechnology ETF by 61.1% during the second quarter. KHP Capital LLC now owns 1,450 shares of the financial services provider’s stock worth $159,000 after purchasing an additional 550 shares in the last quarter. Finally, Truvestments Capital LLC acquired a new position in shares of iShares Nasdaq Biotechnology ETF during the third quarter worth approximately $203,000. Institutional investors own 65.90% of the company’s stock.

IBB opened at $104.15 on Friday. iShares Nasdaq Biotechnology ETF has a fifty-two week low of $100.22 and a fifty-two week high of $122.97.

COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://sportsperspectives.com/2018/11/16/lincoln-national-corp-purchases-shares-of-1778-ishares-nasdaq-biotechnology-etf-ibb.html.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Story: Stock Split

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply